Vanda Pharmaceuticals to Announce Fourth Quarter and Full Year 2022 Financial Results on February 8, 2023

Rhea-AI Summary

Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) is set to release its fourth quarter and full year 2022 financial results on February 8, 2023, after market close. A conference call is scheduled for 4:30 PM ET on the same day, where management will discuss financial results and corporate activities. Interested parties can access the call by dialing 1-800-715-9871 (domestic) or 1-646-307-1963 (international) using passcode 4734670. The call will also be archived on Vanda's website. A replay will be available from 8:30 PM ET on February 8 until 8:30 PM ET on February 15.

Conference Call and Webcast to Follow

WASHINGTON, Feb. 1, 2023 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced it will release results for the fourth quarter and full year 2022 on Wednesday, February 8, 2023, after the market closes.

Vanda will host a conference call at 4:30 PM ET on Wednesday, February 8, 2023, during which management will discuss the fourth quarter and full year 2022 financial results and other corporate activities. To participate in the conference call, please dial 1-800-715-9871 (domestic) or 1-646-307-1963 (international) and use passcode 4734670.

The conference call will be broadcast simultaneously and archived on Vanda's website, www.vandapharma.com. Investors should go to the website at least 15 minutes early to register, download, and install any necessary audio software.

A replay of the call will be available on Wednesday, February 8, 2023, beginning at 8:30 PM ET and will be accessible until Wednesday, February 15, 2023, at 8:30 PM ET. The replay call-in number is 1-800-770-2030 for domestic callers and 1-609-800-9909 for international callers. The passcode number is 4734670.

About Vanda Pharmaceuticals Inc.

Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com and follow us on Twitter @vandapharma.

Corporate Contact:
Kevin Moran
Senior Vice President, Chief Financial Officer and Treasurer 
Vanda Pharmaceuticals Inc.
202-734-3400
pr@vandapharma.com 

Elizabeth Van Every
Head of Corporate Affairs
Vanda Pharmaceuticals Inc.
202-734-3400
pr@vandapharma.com

View original content:https://www.prnewswire.com/news-releases/vanda-pharmaceuticals-to-announce-fourth-quarter-and-full-year-2022-financial-results-on-february-8-2023-301736777.html

SOURCE Vanda Pharmaceuticals Inc.

FAQ

When will Vanda Pharmaceuticals announce its fourth quarter and full year 2022 financial results?

Vanda Pharmaceuticals will announce its financial results on February 8, 2023, after the market closes.

What time is the Vanda Pharmaceuticals conference call for financial results?

The conference call will take place at 4:30 PM ET on February 8, 2023.

How can I access the Vanda Pharmaceuticals conference call?

To access the call, dial 1-800-715-9871 (domestic) or 1-646-307-1963 (international) and use passcode 4734670.

Is there a replay available for the Vanda Pharmaceuticals conference call?

Yes, a replay will be available starting from 8:30 PM ET on February 8, 2023, until 8:30 PM ET on February 15, 2023.